April 2001

SinoMab was incorporated in Hong Kong

August 2010

Shenzhen SinoMab was established in Shenzhen, PRC.

February 2014

Hainan SinoMab was established in Haikou, PRC.

July 2018

SinoLink Pharma was established in Suzhou, PRC.

April 2019

Australia SinoMab was incorporated in Sydney, Australia.

June 2019

SinoMab was recognized as a “Principal Leading Project of the 13th Suzhou Industrial Park Science and Technology Leading Talents Appraisal” (蘇州工業園區第十三屆科技領軍人才重大領軍項目).

November 2019

Successfully listed on HKSE, became the first Hong Kong-based biopharmaceutical company listed on the Main Board

January 2020

Granted the Most Popular Newly Listed Company Award

December 2023

Awarded “The Best Small and Medium Sized Company” at the “8th Zhitong Caijing Listed Companies Awards”